X
ZBH icon

Xponance’s Zimmer Biomet ZBH Stock Holding History

Xponance’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83M Sell
32,875
-186
-0.6% -$16.3K 0.02% 514
2026
Q1 		$2.99M Buy
33,061
+4,636
+16% +$425K 0.02% 478
2025
Q4 		$2.56M Buy
28,425
+1,738
+7% +$165K 0.02% 495
2025
Q3 		$2.63M Sell
26,687
-1,730
-6% -$171K 0.02% 479
2025
Q2 		$2.59M Buy
28,417
+1,014
+4% +$98K 0.02% 481
2025
Q1 		$3.1M Buy
27,403
+213
+0.8% +$22.8K 0.03% 415
2024
Q4 		$2.87M Sell
27,190
-1,103
-4% -$118K 0.03% 439
2024
Q3 		$3.05M Sell
28,293
-8,166
-22% -$891K 0.03% 422
2024
Q2 		$3.96M Sell
36,459
-864
-2% -$102K 0.04% 341
2024
Q1 		$4.93M Buy
37,323
+1,629
+5% +$203K 0.05% 300
2023
Q4 		$4.34M Buy
35,694
+8,945
+33% +$998K 0.05% 294
2023
Q3 		$3M Buy
26,749
+677
+3% +$86K 0.04% 362
2023
Q2 		$3.8M Sell
26,072
-278
-1% -$37.8K 0.05% 309
2023
Q1 		$3.4M Buy
26,350
+860
+3% +$108K 0.05% 328
2022
Q4 		$3.25M Buy
25,490
+3,976
+18% +$461K 0.05% 320
2022
Q3 		$2.25M Buy
21,514
+3,537
+20% +$388K 0.04% 364
2022
Q2 		$1.89M Buy
17,977
+4,284
+31% +$508K 0.04% 389
2022
Q1 		$1.75M Buy
13,693
+145
+1% +$17.5K 0.03% 409
2021
Q4 		$1.67M Buy
13,548
+2,638
+24% +$345K 0.03% 432
2021
Q3 		$1.55M Sell
10,910
-978
-8% -$144K 0.03% 419
2021
Q2 		$1.86M Buy
11,888
+2,779
+31% +$450K 0.03% 387
2021
Q1 		$1.42M Sell
9,109
-135
-1% -$20.9K 0.03% 386
2020
Q4 		$1.38M Buy
9,244
+527
+6% +$74.4K 0.03% 389
2020
Q3 		$1.15M Sell
8,717
-29,849
-77% -$3.9M 0.03% 388
2020
Q2 		$4.47M Buy
+38,566
New +$4.44M 0.12% 162

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Xponance's ZBH Position: Q2 2026 in Review

Xponance reduced its Zimmer Biomet (ZBH) stake by 0.56% in Q2 2026, selling an estimated $16.3K and leaving 32,875 shares worth $2.83M. The position accounts for 0.02% of the portfolio, ranked #514.

Xponance first reported a position in ZBH in Q2 2020 and has held it in 25 quarters since. The position peaked at $4.93M in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Xponance held 32,875 shares of Zimmer Biomet worth $2.83M as of Q2 2026.
  • Xponance sold 186 Zimmer Biomet shares in Q2 2026, an estimated $16.3K.
  • Zimmer Biomet made up 0.02% of Xponance's portfolio in Q2 2026, its #514 holding.
  • Xponance first reported a position in Zimmer Biomet in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Zimmer Biomet position peaked at $4.93M in Q1 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.